This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: Darpan Pandya: Innovator in Macrocyclic Compounds
Introduction
Darpan Pandya is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of macrocyclic compounds, particularly in the development of novel structures that have practical applications in medical diagnostics and treatment.
Latest Patents
Darpan Pandya holds 3 patents, with his latest innovations focusing on tetraaza macrocyclic compounds. One of his patents describes a cross-bridged tetraaza macrocyclic compound that can be utilized as a contrast agent for diagnostic imaging or as a radiopharmaceutical. This compound is designed to form stable metal complexes at lower temperatures, facilitating easier conjugation with bioactive or chemically active substances compared to existing compounds. Another significant patent involves a novel polyazamacrocyclic compound, which serves as a bifunctional chelating agent. This compound can be synthesized selectively and in high yield, allowing it to chelate with metals and conjugate with bioactive molecules, making it useful in diagnosing and treating various medical conditions.
Career Highlights
Darpan Pandya is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work at this institution emphasizes the importance of collaboration between academia and industry, fostering innovation in the field of biomedical applications.
Collaborations
Darpan has worked alongside notable colleagues, including Jeong Soo Yoo and Jeongsoo Yoo. Their collaborative efforts contribute to the advancement of research in macrocyclic compounds and their applications.
Conclusion
Darpan Pandya's innovative work in the field of macrocyclic compounds showcases his commitment to advancing medical technology. His patents reflect a deep understanding of chemical structures and their potential applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile